Abbott has selected a site in Bowling Green for a new manufacturing facility that will produce specialty and metabolic powder nutritional products.

According to JobsOhio, Abbott will invest $536 million into the new facility and create 450 permanent new jobs in the northwest Ohio region.

“Abbott’s history in formula production goes all the way back to Columbus in the early 1900s, and we’re glad Abbott is advancing its future here in Ohio as they bring a cutting-edge facility to Bowling Green that will support job growth and improve the supply chain for critical formula products nationwide,” said Governor DeWine.

“The addition of this new facility will help to ensure that life-sustaining formulas are available and accessible when needed.”

Abbott is a multinational healthcare company whose technologies and products span diagnostics, medical devices, nutritionals, and branded generic medicines.

The project will expand the U.S. supply of essential formulas, some of which serve as the sole source of nutrition for people with extreme allergies to most food products and other dietary and metabolic conditions.